Enocitabine

依诺他滨

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameEnocitabine
Drug Alias Name依诺他宾enocitabinaenocitabinumSunrabinNSC-239336 +[6
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsLeukemia
Global Approved IndicationsLeukemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAsahi Kasei Pharma Corp
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeL01BC
Related LinksWikipediaKEGG